Introduction: Off-Label Uses and High-Cost Drugs: Promotion and Reimbursement Issues

BIO to form marketplace section to represent purchasers of biotechnology: drug share of health spend must increase for investors to see profits—Termeer. Pink Sheet. 1997 Jun 16;59(24):9.

Freudenheim M. Physcor to buy competitor, Medpartners, for $6.8 billion in stock. New York Times. 1997 Oct 30:D1.

Shulman SR Healy E Lasagna L. PBMs: reshaping the pharmaceutical distribution network. J Pharma Market Manage. 1997 Fall; (in press).

Kilborn PT Analysts expect health premiums to rise sharply. New York Times. 1997 Oct 19:A1.

Freudenheim M. Weak results for Oxford and Aetna: signs of trouble in industry seen. New York Times. 1997 Nov 5;2.

Food and Drug Administration Act of 1997 Modernization PL 105–115, November 21, 1997.